Go Deep
Abbott Laboratories
Abbott Laboratories Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 19,820 | 31.6 | 3.24 | 0.63 | 9,378.22 |
| Oct 2026 | 19,820 | 31.5 | 3.24 | 0.63 | 9,377.26 |
| Oct 2026 | 19,820 | 31.5 | 3.24 | 0.63 | 9,377.26 |
| Oct 2026 | 19,680 | 32.3 | 3.33 | 0.63 | 9,627.32 |
| Oct 2026 | 20,031 | 31.7 | 3.26 | 0.63 | 9,464.40 |
| Oct 2026 | 20,031 | 32.3 | 3.26 | 0.63 | 9,464.40 |
| Oct 2026 | 20,001 | 31.8 | 3.28 | 0.63 | 9,530.98 |
| Oct 2026 | 20,014 | 31.8 | 3.27 | 0.63 | 9,507.81 |
| Oct 2026 | 19,686 | 32.1 | 3.31 | 0.63 | 9,636.94 |
| Oct 2026 | 19,528 | 32.8 | 3.38 | 0.63 | 9,748.30 |
| Oct 2026 | 19,802 | 33.1 | 3.41 | 0.63 | 9,771.93 |
| Oct 2026 | 19,744 | 33.2 | 3.42 | 0.63 | 9,776.74 |
| Oct 2026 | 19,650 | 33.7 | 3.48 | 0.63 | 9,940.52 |
| Oct 2026 | 19,638 | 33.8 | 3.49 | 0.63 | 9,934.65 |
| Oct 2026 | 19,684 | 33.6 | 3.46 | 0.63 | 9,866.59 |
| Oct 2026 | 19,772 | 33.0 | 3.40 | 0.63 | 9,713.94 |
| Oct 2026 | 19,878 | 32.4 | 3.34 | 0.63 | 9,506.45 |
| Oct 2026 | 19,764 | 38.1 | 3.41 | 0.63 | 9,676.00 |
| Oct 2026 | 19,698 | 38.5 | 3.45 | 0.63 | 9,828.91 |
Abbott Laboratories Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | — | 11,164,000,000.0 | 11,459,000,000.0 | 11,369,000,000.0 |
| Net Profit | — | 1,077,000,000.0 | 1,776,000,000.0 | 1,644,000,000.0 |
| EPS | 0.5 | 0.6 | 1.0 | 0.9 |
Abbott Laboratories Revenue & Profit: Last 5 Years
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Revenue | 44,328,000,000.0 | 41,950,000,000.0 | 40,109,000,000.0 | 43,653,000,000.0 | — |
| Net Profit | 6,524,000,000.0 | 13,402,000,000.0 | 5,723,000,000.0 | 6,933,000,000.0 | — |
| EPS | 3.8 | 7.7 | 3.3 | 4.0 | — |
Abbott Laboratories Balance Sheet
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Total Assets | 86,713,000,000.0 | 81,414,000,000.0 | 73,214,000,000.0 | 74,438,000,000.0 | — |
| Total Liabilities | 33,942,000,000.0 | 33,513,000,000.0 | 34,387,000,000.0 | 37,533,000,000.0 | — |
| Total Equity | 52,130,000,000.0 | 47,664,000,000.0 | 38,603,000,000.0 | 36,686,000,000.0 | — |
Owes vs Owns
Abbott Laboratories owed $0.52 for every $1 it owned in Mar 2026, up from $0.50 in Dec 2022.
| Period | Mar 2026 | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.52× | 0.39× | 0.41× | 0.47× | 0.50× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Abbott Laboratories Assets & Liabilities Breakdown (USD millions)
What it owns — Dec 2025
Cash & short-term investments 10.3%Receivables 12.2%Inventory 7.5%Fixed assets (tangible) 13.6%Intangible assets 34.1%Long-term investments 1.1%Other assets 21.2%
How it's funded — Dec 2025
Short-term debt 3.5%Long-term debt 11.4%Payables 4.9%Other liabilities 19.3%Shareholders' equity 60.9%
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 8,939.0 | 7,967.0 | 7,279.0 | 10,170.0 |
| Receivables | 10,569.0 | 9,495.0 | 8,821.0 | 8,881.0 |
| Inventory | 6,488.0 | 6,194.0 | 6,570.0 | 6,173.0 |
| Fixed assets (tangible) | 11,816.0 | 10,658.0 | 10,154.0 | 9,162.0 |
| Intangible assets | 29,561.0 | 29,755.0 | 32,494.0 | 33,253.0 |
| Long-term investments | 918.0 | 886.0 | 799.0 | 766.0 |
| Other assets | 18,422.0 | 16,459.0 | 7,097.0 | 6,033.0 |
| Liabilities & equity | ||||
| Short-term debt | 3,033.0 | 1,500.0 | 1,080.0 | 2,251.0 |
| Long-term debt | 9,896.0 | 12,625.0 | 13,599.0 | 14,522.0 |
| Payables | 4,240.0 | 4,195.0 | 4,295.0 | 4,607.0 |
| Other liabilities | 16,773.0 | 15,193.0 | 15,413.0 | 16,153.0 |
| Shareholders' equity | 52,771.0 | 47,901.0 | 38,827.0 | 36,905.0 |
| Net tangible assets | 22,569.0 | 17,909.0 | 6,109.0 | 3,433.0 |
Abbott Laboratories Cash Flow
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Operating Activities | 9,566,000,000.0 | 8,558,000,000.0 | 7,261,000,000.0 | 9,581,000,000.0 | — |
| Investing Activities | -2,422,000,000.0 | -2,338,000,000.0 | -3,133,000,000.0 | -1,740,000,000.0 | — |
| Financing Activities | -6,309,000,000.0 | -5,404,000,000.0 | -7,091,000,000.0 | -7,636,000,000.0 | — |